PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

PSMA-PET imaging not the most cost-effective option for many prostate cancer patients
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.
Inflammation-targeting PET method predicts recovery after heart attack
Targeting CXCR4 during PET scans could help providers gain vital information regarding patients' potential to fully recover from myocardial infarction.
Nuclear cardiology expands beyond perfusion imaging as it enters a new era
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
PET holds promise for carotid plaque assessments
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
Imaging offers insight into impact of new Alzheimer's treatment from Eli Lilly
Emerging research provides further evidence that amyloid-removal treatment for Alzheimer’s effectively slows cognitive decline.

Machine learning combined with PET/CT can predict heart attack risk

“We showed that risk prediction does not depend on cardiovascular risk scores, stenosis severity or CT calcium scoring," researchers said in the Journal of Nuclear Medicine.

Physicians support use of PET/CT scans in pregnant women with cancer, survey finds

Researchers say scans pose little risk to an unborn fetus but maintained doctors must weigh the benefits against potential risks.

‘Partial victory’: Imaging advocates say Humana relenting on some PET/CT payment restrictions

The health insurer reversed its coverage denial for imaging of gastric and esophageal oncologic indications, while other restrictions remain in place.

Humana agrees to take second look at panned payment change labeling PET/CT as ‘investigational’

The American Society of Nuclear Cardiology recently met with the Louisville, Kentucky, insurer, which shared an openness to reviewing a recent coverage determination.

Nuclear medicine, cardio groups reject proposed myocardial PET cuts

Multiple nuclear medicine and cardiology groups are working to oppose potential cuts to myocardial PET scans that were made possible by the CMS 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, according to a joint statement.

Industry groups oppose proposed myocardial PET cuts

When CMS released the 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, it included revisions that could lead to technical component payment reductions of up to 80% for certain services related to myocardial PET scans.

At ASTRO, Siemens Healthineers unveil RT Pro Edition for Biograph Vision for PET/CT radiation therapy planning

RT package of latest PET/CT scanner offers comprehensive therapy planning solution.

SNMMI, ASNC encourage BCBS to expand coverage of cardiac PET

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear Cardiology (ASNC) submitted a letter to BlueCross BlueShield (BCBS) of Tennessee urging an expansion of cardiac PET coverage.

PET/CT

PSMA-PET imaging not the most cost-effective option for many prostate cancer patients

Inflammation-targeting PET method predicts recovery after heart attack

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

PET holds promise for carotid plaque assessments

Imaging offers insight into impact of new Alzheimer's treatment from Eli Lilly